Spotlight
Topic
Brand Insights
- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook
Exploring the most relevant topics affecting the biopharma industry as the new year gets underway—ranging from trends ripe with risk and opportunity to those driving more definitive growth opportunities in patient care.
Articles in this issue
Key Factors Attributing to a Successful Product Launch
Closing the Digital Gap: FDA’s Oversight of Social Media
Sales-Rep Compensation: Adding Long-Term Incentives to Mix
Stars Aligned for Pricing Model? Value-Based Contracts May be Poised for Takeoff
Co-creating New Innovations
The Potential Impact of the IRA
Patient Hubs Continue Growth
Social Media’s Complex Climb
Industry Workforce Seeks Clarity
Cybersecurity Threats & Pharma
What We Foresee in ’23: Pharm Exec’s Annual Industry Outlook
Enabling Authenticity
Biopharma Investment Implications: Looking Back and Forward
Payer Key Business Factors for Orphan Product Launches
Innovating the Go-to-Market Model in Asia
Related Videos
Related Content
Fierce Females in the Life Science Space
March 29th 2024Podcast
In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands.
